Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis

Objectives: To evaluate the role of immunological tests for monitoring lupus nephritis (LN) activity. Methods: C3, C4, anti-dsDNA and anti-C1q antibodies were prospectively performed over 6 years in 228 patients with LN. Results: In membranous LN only anti-C1q antibodies differentiated proteinuric flares from quiescent disease (p = 0.02). However, in this group 46% of flares occurred with a normal value of anti-C1q antibodies versus 20% in proliferative LN (p = 0.02). In patients with antiphospholipid antibodies (APL), 33% of flares occurred with normal levels of anti-C1q antibodies versus 14.5% in patients that were APL-negative (p = 0.02). In proliferative LN, anti-C1q antibodies showed a slightly better sensitivity and specificity (80.5 and 71% respectively) than other tests for the diagnosis of renal flares. All four tests had good negative predictive value (NPV). At univariate analysis anti-C1q was the best renal flare predictor (p<0.0005). At multivariate analysis, the association of anti-C1q with C3 and C4 provided the best performance (p<0.0005, p<0.005, p<0.005 respectively). Conclusions: Anti-C1q is slightly better than the other tests to confirm the clinical activity of LN, particularly in patients with proliferative LN and in the absence of APL. All four “specific” tests had a good NPV, suggesting that, in the presence of normal values of each, active LN is unlikely.

[1]  E. G. de la Concha,et al.  GDF5 Polymorphism associated with osteoarthritis: risk for rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[2]  L. Magder,et al.  Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. , 2001, Arthritis and rheumatism.

[3]  F. Breedveld,et al.  Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  R. Gupta,et al.  Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus. , 1999, The Indian journal of medical research.

[5]  Y. Goekoop-Ruiterman,et al.  Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis , 2008, Annals of the rheumatic diseases.

[6]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[7]  M. Abrahamowicz,et al.  Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. , 1996, Arthritis and rheumatism.

[8]  Y. Levy,et al.  Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. , 2004, Arthritis and rheumatism.

[9]  A. V. Ivanova,et al.  [Classification of systemic lupus erythematosus]. , 1971, Terapevticheskii arkhiv.

[10]  G. Hughes,et al.  Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus , 2004, Annals of the rheumatic diseases.

[11]  S. Sadallah,et al.  High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  F. Breedveld,et al.  Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. , 1993, Annals of the rheumatic diseases.

[13]  R. Sinico,et al.  Anti‐C1q Autoantibodies in Lupus Nephritis: Prevalence and Clinical Significance , 2005, Annals of the New York Academy of Sciences.

[14]  G. Hughes,et al.  Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus , 2004, Annals of the rheumatic diseases.

[15]  A. Tyndall,et al.  Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. , 1999, Arthritis and rheumatism.

[16]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[17]  D. Isenberg,et al.  An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. , 2001, Rheumatology.

[18]  S. Quaglini,et al.  "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. , 1996, Kidney international.

[19]  S. Quaglini,et al.  Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  S. Goldring Periarticular bone changes in rheumatoid arthritis: pathophysiological implications and clinical utility , 2009, Annals of the rheumatic diseases.